BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26250129)

  • 1. [Characteristics of group A patients according to the ABC classification for gastric cancer risk screening].
    Yoshizawa K; Oizumi H; Sasaki Y; Abe Y; Kanno N; Sakuta K; Yagi M; Iwano D; Sato T; Nomura E; Nishise S; Ueno Y
    Nihon Shokakibyo Gakkai Zasshi; 2015 Aug; 112(8):1492-502. PubMed ID: 26250129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.
    Kiso M; Yoshihara M; Ito M; Inoue K; Kato K; Nakajima S; Mabe K; Kobayashi M; Uemura N; Yada T; Oka M; Kawai T; Boda T; Kotachi T; Masuda K; Tanaka S; Chayama K
    Gastric Cancer; 2017 Sep; 20(5):764-771. PubMed ID: 28025702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic evaluation by the Kyoto classification of gastritis combined with serum anti-Helicobacter pylori antibody testing reliably risk-stratifies subjects in a population-based gastric cancer screening program.
    Hirai R; Hirai M; Otsuka M; Mitsuhashi T; Shimodate Y; Mouri H; Matsueda K; Yamamoto H; Mizuno M
    J Gastroenterol; 2023 Sep; 58(9):848-855. PubMed ID: 37340218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative study of new gastric cancer screening scoring system and new ABC method for screening gastric cancer and precancerous lesions].
    Wang XT; Ji ZZ; Han F; Lyu B
    Zhonghua Nei Ke Za Zhi; 2021 Mar; 60(3):227-232. PubMed ID: 33663171
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan.
    Saito S; Azumi M; Muneoka Y; Nishino K; Ishikawa T; Sato Y; Terai S; Akazawa K
    Eur J Health Econ; 2018 May; 19(4):545-555. PubMed ID: 28550494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABC Classification Is Less Useful for Older Koreans Born before 1960.
    Kwon H; Lee SY; Kim JH; Lee SP; Kim JH; Sung IK; Park HS; Shim CS
    Gut Liver; 2019 Sep; 13(5):522-530. PubMed ID: 30970432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels--The ABC Method.
    Yamaguchi Y; Nagata Y; Hiratsuka R; Kawase Y; Tominaga T; Takeuchi S; Sakagami S; Ishida S
    Digestion; 2016; 93(1):13-8. PubMed ID: 26789514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
    Watanabe M; Kato J; Inoue I; Yoshimura N; Yoshida T; Mukoubayashi C; Deguchi H; Enomoto S; Ueda K; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Tekeshita T; Mohara O; Ushijima T; Ichinose M
    Int J Cancer; 2012 Dec; 131(11):2632-42. PubMed ID: 22383377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
    Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
    Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
    Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
    Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings.
    Kotachi T; Ito M; Yoshihara M; Boda T; Kiso M; Masuda K; Matsuo T; Tanaka S; Chayama K
    Digestion; 2017; 95(4):314-318. PubMed ID: 28571035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.
    Boda T; Ito M; Yoshihara M; Kitamura Y; Matsuo T; Oka S; Tanaka S; Chayama K
    Helicobacter; 2014 Feb; 19(1):1-8. PubMed ID: 24215601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".
    Miki K
    Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(7):405-14. PubMed ID: 21785258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
    Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
    J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastric cancer risk classification (ABC classification)].
    Inoue K
    Nihon Rinsho; 2013 Aug; 71(8):1472-8. PubMed ID: 23967682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method.
    Furihata C
    Proc Jpn Acad Ser B Phys Biol Sci; 2021; 97(8):462-478. PubMed ID: 34629355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new modified ABCD method for gastric neoplasm screening.
    Park CH; Kim EH; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
    Gastric Cancer; 2016 Jan; 19(1):128-35. PubMed ID: 25663259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen.
    Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Nishida J
    Anticancer Res; 2015 Dec; 35(12):6765-71. PubMed ID: 26637894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.